rdf:type |
|
lifeskim:mentions |
|
pubmed:dateCreated |
2003-12-17
|
pubmed:abstractText |
This open-label, non-comparative study was conducted at a single center to evaluate the effects on the endometrium of a 24-day regimen of a combined oral contraceptive containing gestodene (GTD) 60 microg and ethinylestradiol (EE) 15 microg.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1362-5187
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
4 Suppl 2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14677619-Adult,
pubmed-meshheading:14677619-Contraceptives, Oral, Combined,
pubmed-meshheading:14677619-Contraceptives, Oral, Synthetic,
pubmed-meshheading:14677619-Drug Administration Schedule,
pubmed-meshheading:14677619-Endometrium,
pubmed-meshheading:14677619-Estrogens,
pubmed-meshheading:14677619-Ethinyl Estradiol,
pubmed-meshheading:14677619-Female,
pubmed-meshheading:14677619-Humans,
pubmed-meshheading:14677619-Menstrual Cycle,
pubmed-meshheading:14677619-Norpregnenes,
pubmed-meshheading:14677619-Time Factors
|
pubmed:year |
1999
|
pubmed:articleTitle |
An open-label study of the effects of a 24-day regimen of gestodene 60 microg/ethinylestradiol 15 microg on endometrial histological findings in healthy women.
|
pubmed:affiliation |
Bosch Medicentrum, Groot Ziekengasthuis, Den Bosch, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|